US OptionsDetailed Quotes
COIN241129C335000
- 0.86
- -3.69-81.10%
15min DelayClose Nov 26 16:00 ET
2.75High0.75Low
2.00Open4.55Pre Close1.03K Volume1.38K Open Interest335.00Strike Price146.39KTurnover108.68%IV14.51%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier2DDays to Expiry0.86Extrinsic Value100Contract SizeAmericanOptions Type0.0750Delta0.0054Gamma345.05Leverage Ratio-0.6270Theta0.0014Rho25.87Eff Leverage0.0341Vega
Coinbase Stock Discussion
MicroStrategy: +55% $MicroStrategy (MSTR.US)$
Coinbase: +51% Tesla: +35% $Coinbase (COIN.US)$
Bitcoin: +32% Banks: +14% $Bitcoin (BTC.CC)$
Small Caps: +7.3% $iShares Russell 2000 ETF (IWM.US)$
S&P 500: +4.2% $S&P 500 Index (.SPX.US)$
US Dollar: +3.7% $USD (USDindex.FX)$
US Bonds: +0.2%
---
International Stocks: -3.1%
Oil: -4.2%
Gold: -4.2%
Pfizer: -6.8% $Pfizer (PFE.US)$
China: -9.6%
Trump Media: -10% $Trump Media & Technology (DJT.US)$
Moderna: -21% $Moderna (MRNA.US)$
...
Cantor is also exploring Tether-backed Bitcoin collateralized loans, initially valued at $2 billion.
$Donald Trump (LIST22962.US)$ $Trump Media & Technology (DJT.US)$ $Coinbase (COIN.US)$ $MicroStrategy (MSTR.US)$ $MARA Holdings (MARA.US)$ $Crypto Spot ETF (LIST21030.US)$ $Bitwise Bitcoin ETF (BITB.US)$
In this environment, U.S. equities have been volatile. The 'Trump trade' initially surged, pulled back on concerns about reflation, and then began to rebound. Since election day, the $S&P 500 Index (.SPX.US)$ has risen...
Gapping up
$Poseida Therapeutics (PSTX.US)$' stock jumped over 200%. This happened because Roche, a Swiss company, is buying Poseida for up to $1.5 billion in cash.
Shares of weight-loss drug maker $Novo-Nordisk A/S (NVO.US)$ and $Eli Lilly and Co (LLY.US)$ rose 2.1% and 4.9% respectively on Tuesday as U.S. President Jo Biden proposed expanding coverage of anti-obesity drugs for millions on Medicare and Medicaid...
Bessent has advocated for cutting taxes and reducing government spending and regulations. Bessent would also focus on enacting tariff, slaying inflation and maintaining the U.S. dol...
No comment yet